Of the fast ionotropic synapses, glycinergic synapses are the least well understood, but are vital for the maintenance of inhibitory signaling in the brain and spinal cord. Glycinergic signaling comprises half of the inhibitory signaling in the spinal cord, and glycinergic synapses are likely to regulate local nociceptive processing as well as the transmission to the brain of peripheral nociceptive information. Here we have investigated the rapid and prolonged potentiation of glycinergic synapses in the superficial dorsal horn of young male and female mice after brief activation of NMDA receptors (NMDARs). Glycinergic inhibitory postsynaptic currents (IPSCs) evoked with lamina II-III stimulation in identified GABAergic neurons in lamina II were potentiated by bath-applied Zn 2+ and were depressed by the prostaglandin PGE2, consistent with the presence of both GlyRα1-and GlyRα3-containing receptors. NMDA application rapidly potentiated synaptic glycinergic currents. Whole-cell currents evoked by exogenous glycine were also rapidly potentiated by NMDA, indicating that the potentiation results from altered numbers or conductance of postsynaptic glycine receptors. Repetitive depolarization alone of the postsynaptic GABAergic neuron also potentiated glycinergic synapses, and intracellular EGTA prevented both NMDA-induced and depolarization-induced potentiation of glycinergic IPSCs. Driving trpv1 lineage afferents optogenetically also triggered NMDAR-dependent potentiation of glycinergic synapses. Our results suggest that during peripheral injury or inflammation, nociceptor firing during injury is likely to potentiate glycinergic synapses on GABAergic neurons. This disinhibition mechanism may be engaged rapidly, altering dorsal horn circuitry to promote the transmission of nociceptive information to the brain.
Introduction
In the superficial dorsal horn, thermal, mechanical, and nociceptive information is processed and then relayed to the brain via ascending inputs. The wiring diagram of nociceptive information flow in the dorsal horn is far from complete, but inhibitory synapses have long been recognized as important points of control restricting the transmission of pain information to the brain (Baldo et al. 2003; Latremoliere and Woolf 2009; Torsney and MacDermott 2006; Woolf et al. 1994; Yaksh 1989; Zeilhofer et al. 2012a; Zeilhofer et al. 2012b) . Pharmacological disinhibition allows afferents from low-threshold mechanosensory cells to drive lamina I projection neurons in vitro (Baba et al. 2003; Torsney and MacDermott 2006) . Glycine receptors (GlyRs) are most prevalent in caudal brain regions and in the spinal cord, where they mediate a large proportion of inhibitory neurotransmission (Altschuler et al. 1986; Alvarez et al. 1997) . Either acute blockade (Foster et al. 2015; Yaksh 1989) or chronic loss (Coull et al. 2003; Sivilotti and Woolf 1994; Zeilhofer 2008) of glycinergic transmission in the spinal cord results in allodynia, hyperalgesia, and itch, while a GlyR allosteric modulator reduces neuropathic pain (Huang et al. 2017) .
Glycinergic neurons in the dorsal horn and brainstem innervate both excitatory and inhibitory neurons in the superficial laminae. GlyRs are ligand-gated ion channels, members of the cysloop superfamily that includes GABAA receptors, 5HT3 receptors, and nicotinic nACh receptors.
Like GABAA receptors, glycine receptors are chloride channels and generally act to hyperpolarize cells and stabilize the membrane potential. Glycine receptors exist as heteromeric pentamer complexes of alpha (α1-4) and β subunits. The β subunits bind to the scaffolding protein, gephyrin to stabilize (Tyagarajan and Fritschy 2014) . After very early postnatal development, synaptic GlyRs in the dorsal horn are heteromers composed of α1, α3, and β subunits (Becker et al. 1988; Harvey et al. 2004; Malosio et al. 1991) , and α3 subunits in the dorsal horn may be preferentially required for nociception (Harvey et al., 2004 , Huang et al., 2017 ).
Long-term potentiation (LTP) is a characteristic of many excitatory brain synapses, and has also been reported at glutamatergic synapses made by primary afferents in the dorsal horn (Ikeda et al. 2003; Liu and Sandkuhler 1995; Randic et al. 1993) . However, nearly nothing is known about mechanisms of plasticity at glycinergic synapses. We reported previously that LTP is induced at glycinergic synapses on GABAergic neurons in the dorsal horn by the proinflammatory cytokine interleukin 1β, (IL-1β) (Chirila et al. 2014) , which is released in the dorsal horn following injury (Raghavendra et al. 2004; Samad et al. 2001; Whitehead et al. 2010) . The same glycinergic synapses were maximally potentiated shortly after in vivo inflammation, and we hypothesized that glycine receptor LTP in this model was caused by local release of IL-1β during peripheral inflammation. Here we have identified other mechanisms that potentiate glycinergic synapses.
In cultured spinal cord neurons, NMDA can increase glycinergic currents (Xu et al. 2000) . Singleparticle tracking experiments showed that clusters of GlyRs and miniature IPSC amplitudes are markedly increased after treatment with NMDA, but receptor clustering is prevented if Ca 2+ is chelated (Levi et al. 2008) . Elevation of intracellular Ca 2+ was also reported to potently increase glycine receptor single channel openings (Fucile et al. 2000) in cultured cells or when heterologously expressed. Because of the relative paucity of information about glycinergic synapse plasticity and its potential importance in modulating nociception, we are interested in characterizing glycinergic synapses and the control of their synaptic strength in situ in the dorsal horn. We find that bath-applied NMDA causes a long-lasting potentiation of these glycinergic synapses through a postsynaptic mechanism. Simply depolarizing GABAergic neurons repetitively also potentiates glycinergic synapses, and both depolarization-and NMDA-induced potentiation are prevented by chelation of postsynaptic Ca 2+ . Furthermore, NMDAR activation by primary nociceptors also potentiated glycinergic synapses. Together, our findings suggest that glutamate released from primary nociceptive afferents during peripheral damage could act at NMDARs on inhibitory dorsal horn neurons to promote persistent potentiation of glycinergic synapses.
Materials and Methods

Animals
All experiments were conducted in strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory animals and as approved by the Brown Institutional Animal Care and Use Committee. Animals included Tg(Gad2-EGFP)DJ31Gsat/Mmucd mice (GENSAT project, Rockefeller University; http://www.gensat.org), backcrossed more than ten times on the Swiss Webster background prior to use in this study. Hemizygous GAD65-EGFP mice were mated to Swiss Webster mice in each generation and were used as hemizygotes. Trpv1-Cre and lox-STOP-lox-ChR2-EYFP mice were purchased from The Jackson Laboratory. For optogenetic experiments, trpv1-Cre +/+ mice were mated with ChR2-EYFP+/+ mice to generate trpv1 +/-/ChR2-EYFP +/-offspring (referred to here as TRPV1/ChR2). Both male and female mice of all genotypes (p25-p40) were maintained on a 12h light/dark cycle and were provided food and water ad libitum. Data taken from both male and female mice were included in this study, and no significant sex differences were identified. Animals were deeply anesthetized with isoflurane and then injected with a terminal dose of ketamine (75 mg/kg) and dexmedetomidine (1 mg/kg). Mice were then transcardially perfused with cutting solution containing (in mM) 92 choline chloride, 1.2 NaH2PO4, 1.2 NaHCO3, 20 HEPES, 25 dextrose, 5 Na-ascorbate, 2 thiourea, 3 Na-pyruvate, 10 MgSO4, 0.5 CaCl2 (Mainen et al. 1999; Ting et al. 2014 ) that was bubbled with 95% O2 and 5% CO2. Animals were then decapitated, and the spinal cord was rapidly dissected from the ventral aspect. Transverse lumbar spinal cord slices (300 µm thick) were prepared as described previously (Chirila et al. 2014) . Slices were incubated at 34°C for 1 hour prior to recording in oxygenated recording ACSF containing (in mM) 119 NaCl, 2.5 KCl, 2.5
CaCl2, 1 NaH2PO4, 1.3 MgSO4, 26 NaHCO3, 1.3 Na-ascorbate, 25 dextrose) and then stored at room temperature until use.
Electrophysiology and optogenetics
Slices were continuously perfused with oxygenated ACSF at room temperature at a rate of 1 ml/min. To limit heterogeneity, recordings were restricted to the lateral area of dorsal horn lamina II. GABAergic neurons were visually identified, and only recordings from neurons that expressed GFP are included in this study, with the exception of experiments from trpv1-ChR2: optogenetic experiments were made from unlabeled lamina II neurons in slices from these mice. Currentclamp recordings were made at the start of every experiment to observe action potential firing patterns in response to current steps of 50 pA delivered starting at resting membrane potential every 10 seconds. Neurons with resting membrane potentials less than -55 mV or with holding currents greater than 50 pA were not considered healthy and were eliminated from further study.
Gly IPSCs were evoked at 0.1 Hz using a stainless steel stimulating electrode placed lateral to the recording site in lamina II; and isolated using bicuculline (30 µM) and 6,7-dintroquinaloxine-2,3-dione (DNQX, 10 µM) to block GABAAR and AMPAR currents, respectively. Remaining synaptic currents were blocked by strychnine to confirm that they are glycinergic. IPSCs were recorded as inward currents using pipettes filled with KCl-based internal solution containing (in mM): 125 KCl, 2.8 NaCl, 10 HEPES, 2 MgCl2, 4 Na-ATP, 0.3 Na-GTP, 10 Na-phosphocreatine, 0.6 EGTA. In some experiments EGTA was increased to 15 mM in the pipette solution, as noted.
In these experiments, neurons were held for at least 20 minutes after breaking into whole-cell mode before another manipulation. For occlusion experiments NMDA (50µm) was bath applied for 5 min. If glycine inputs potentiated by more than 20%, IL-1β (10ng/ml, 10 min) was added to the bath at least 20 min following NMDA washout when IPSCs reached a steady state. For optogenetic experiments with low-frequency stimulation (LFS) of nociceptive inputs in TRPV1/ChR2 animals, an optic fiber (230µm diameter) was placed at the dorsal slice edge to stimulate TRPV1/ChR2 primary afferents with light (Plexon LED, 465nM, 0.5 -1ms, 1-9mW).
Presence of TRPV1/ChR2 input was determined in each slice/cell before bath application of DNQX. LFS was carried out in presence of bicuculline and DNQX; we stimulated each cell with a light train of 2 Hz for 2 min while voltage-clamped at -40mV at a 2ms light pulse duration. All pharmacological agents, including NMDA, were bath-applied at known concentrations unless otherwise indicated. Bicuculline and PGE2 were dissolved in DMSO; the final concentration of DMSO in experimental ACSF solution was 0.03% and 0.1%, respectively. All other pharmacological agents were dissolved in water.
Statistical Analysis
All data are presented as mean ± SEM of the percent change in IPSC amplitude. Potentiation was measured at 12-17 minutes after NMDA application for NMDA-induced Gly LTP, or 15 minutes after the start of drug application. For PPR analysis, 60 IPSCs before and at 10-20 min after the start of NMDA or after depolarization were averaged; cells were included in PPR analysis if they exhibited at least 20% LTP above baseline values. Figure 3B -C includes all experiments in which NMDA alone was bath-applied; some of the same experiments were interleaved with experimental treatments and are therefore also reported in other figures as "control cells". Significance was determined using paired t-tests with a significance level of p<0.05 except where noted when unpaired t-tests or one-way ANOVA were used as appropriate.
Results
We recorded from eGFP-labeled GAD-65 neurons in lamina II of the dorsal horn. This population of cells exhibited three main firing patterns in response to direct current injection ( Figure 1A -B).
The majority of neurons fired 1-3 action potentials in 300 ms (initial firing type, 60/141), while other cells exhibited either tonic firing throughout the pulse (54/141) or a delayed or "gap" mode of firing that is characteristic when A-type K + currents are present (27/141) (Yasaka et al., 2010 ).
Cells we included in the gap/delay class sometimes fired an initial spike followed by a gap before resuming. The action potential threshold was significantly lower for tonic firing cells than for initial or gap/delay cells ( Figure 1C ; initial vs tonic, p<0.0001, gap vs. tonic, p<0.0001, one-way ANOVA, Tukey's multiple comparisons test; n=60 initial, n=54 tonic, n=27 gap/delay), while the input resistance, and the rise time and decay time of evoked Gly IPSCs did not significantly differ among the classes ( Figure 1D -F).
GlyRs in lateral dorsal horn lamina II contain both α1 and α3 subunits.
Both GlyRα1 and GlyRα3 subunits have been reported in lamina II, and GlyRα3 in particular has been implicated in inflammatory pain (Harvey et al. 2004) . Previous work has shown that Zn 2+ is an allosteric modulator of glycine receptors, transiently potentiating glycinergic synapses containing GlyRα1 (Lynch et al. 1998; Miller et al. 2005) , while prostaglandin E2 (PGE2) depresses glycinergic synapses containing GlyRα3 (Harvey et al. 2004; Cantaut-Belarif et al. 2017) . Using these tools, we tested which receptor subunits were present in glycinergic synapses on the GABAergic neurons of lamina II. Glycinergic inhibitory postsynaptic currents (Gly IPSCs) were evoked using a stimulating electrode placed laterally nearby in lamina II. Bathapplication of ZnCl2 (1 µM) increased glycinergic IPSC amplitudes ( We therefore tested whether NMDA-induced Gly LTP shares synaptic mechanisms with IL-1β-induced potentiation. We first bath-applied NMDA, and then upon stable potentiation of Gly IPSCs, we applied IL-1β. As shown in Figure 3H -J, after NMDA-induced potentiation (135±40%, n=6, paired t-test baseline vs. NMDA: p=0.03) IL-1β produced no further significant potentiation (93±32%, n=6, paired t-test NMDA vs. IL-1β: p=0.63), suggesting a shared underlying mechanism. We also attempted applying IL-1β followed by NMDA, however after the synapses potentiated with IL-1β, NMDA invariably produced synaptic depression (data not shown). These results support the idea that IL-1β and NMDA potentiate glycine synapses via a common cellular mechanism.
NMDA-induced Gly LTP is mediated postsynaptically
LTP can result either from an increase in presynaptic neurotransmitter release or from an increase in postsynaptic receptor number or function, and the short-term dynamics of synaptic activation can be used to infer the locus of synaptic change. The paired-pulse ratio (PPR) is a useful measure, decreasing if the probability of neurotransmitter release increases during LTP (Salin et al. 1996; Staubli et al. 1990; Zalutsky and Nicoll 1990) . On average, during Gly LTP the PPR remained unchanged after NMDAR application, suggesting that LTP is not caused by an increase in transmitter release, but instead by increased postsynaptic glycine receptor number or conductance (Figure 4A -B; PPR control, 1.18 ± 0.05; post-NMDA, 1.17 ± 0.07; p=.86, n=26).
To test this more directly, we measured whole-cell postsynaptic currents evoked by exogenous bath-applied glycine. These glycine currents are independent of presynaptic glycine release, and so any increase after NMDA can only result from postsynaptic changes. Glycine (3 mM) was applied for 30 s every ten minutes, and the resulting inward currents were recorded (Chirila et al. 2014) . Control measurements were acquired by washing on glycine 2-3 times, and then NMDA (50 µM) was bath applied for five minutes. Following application of NMDA, exogenous glycine currents were significantly increased (Figure 4D -E; glycine currents after NMDA: 275 ± 30.5% of baseline, p=0.011, n=10). Together, our results suggest that NMDA Gly LTP depends upon an increase in number and/or function of GlyRs and is independent of glycine release.
Postsynaptic calcium is required for NMDAR Gly LTP and sufficient to potentiate Gly IPSCs
Many forms of synaptic plasticity require a rise in postsynaptic calcium (Chirila et al. 2014; Herring and Nicoll 2016; Malenka et al. 1988) , and the high Ca 2+ permeability of the NMDAR is required for the majority of signaling through this channel. To determine whether NMDAR Gly LTP is calcium-dependent, we included EGTA (15 mM) in the recording pipette to chelate postsynaptic intracellular calcium. Compared with same-day control recordings, high intracellular EGTA blocked NMDAR Gly LTP (0.6 mM EGTA, 134 ± 12.06% of baseline, p=0.03, n=7; 15 mM EGTA, 95 ± 12.6% of baseline, p=0.73, n=8; Figure 5A -C) suggesting that elevated intracellular calcium is necessary for NMDAR Gly LTP. To determine whether elevated Ca 2+ alone is sufficient to potentiate Gly synapses, GABAergic neurons were repetitively depolarized to -10 mV at 0. p=0.023). Together, the results suggest that postsynaptic Ca 2+ is necessary for NMDAR Gly LTP, and that postsynaptic calcium entry is also sufficient to potentiate glycinergic synapses.
Brief low-frequency stimulation of nociceptor afferents potentiated Gly IPSCs through NMDA receptors
Sensitization of nociceptors is typically accompanied by an increased spontaneous discharge pattern of peripheral nociceptors, which induces changes in synaptic strength with dorsal horn neurons (Ikeda et al. 2006 , Pradier et al. 2018 . While GlyR LTP was elicited by either bathapplied NMDA or experimenter-induced postsynaptic depolarization, both methods represent relatively unphysiological stimuli. To test our observations in a more physiological context, we next investigated whether Gly IPSCs could be potentiated upon activation of primary nociceptor afferents at frequencies occurring during injury or inflammation. We used TRPV1/ChR2 transgenic mice as recently described (Cavenaugh et al., 2008; Pradier et al. 2018 ) to optogenetically activate nociceptor afferents at a frequency that has been suggested to occur naturally during painful peripheral stimuli (Puig and Sorkin, 1996; Ikeda et al., 2006) . Stimulation of nociceptors with light evoked glutamatergic synaptic events but not direct release of glycine Pradier et al., 2018) . We recorded Gly IPSCs in lamina II neurons in the presence of bicuculline and DNQX to allow isolated Gly IPSC recordings, however NMDARs were not blocked to permit activation of NMDARs through primary afferents. After a stable period of electrically-evoked Gly IPSCs, electrical stimulation was paused, and for 2 minutes 2 Hz light pulses were delivered NMDA induced glycine potentiation requires a rise in intracellular Ca 2+ , and repetitive depolarization alone also potentiates the synapses in a Ca 2+ -dependent manner. Finally, NMDAR activation induced by synaptic stimulation of trpv1-lineage nociceptor afferents also potentiates glycinergic synapses.
Firing properties of GAD-65 labelled lamina II neurons
Dividing dorsal horn neurons into functionally relevant subgroups has been crucial in beginning to define the circuits of this complex and heterogeneous structure (Peirs and Seal 2016; Todd 2017). In our experiments, neurons in lamina II labeled genetically with eGFP under the GAD-65 promoter exhibited three distinct firing modes in response to depolarizing pulses (initial, tonic, and gap/delay). Previous work using either genetic labeling or peptide co-localization suggested that delayed or gap firing is a hallmark of excitatory interneurons, while tonic firing is more 
Glycine receptors on lamina II GABAergic neurons
Using Zn 2+ to probe for α1-containing receptors and PGE2 to probe for α3-containing receptors, we found that all but one of our recorded glycinergic synaptic currents potentiated with Zn 2+ , and the majority but not all exhibited synaptic depression with PGE2. Our results suggest that glycinergic synapses on this GABAergic population have α1-containing receptors, but may also contain α3-containing receptors, either as α1/α3/β heteromers or as α1β or α3β homomeric channels. Using immunocytochemistry, previous work indicated that approximately half of lamina II neurons appear to co-express both subunits, and our data in the GAD-65 cell population are consistent with these results (Harvey et al., 2004) . Recent work in cultured neurons indicates that IL-1β does not affect GlyRα3-containing receptors, although IL-1β potentiation of GlyRα1-containng receptors was not observed in this study (Patrizio et al., 2017) .
NMDA-induced Gly LTP mechanisms
Brief bath-application of NMDA effectively potentiated glycinergic synapses on lamina II GABAergic neurons. The potentiation typically began within minutes of NMDA application, and persisted long after NMDA was washed out. We observed NMDA LTP in GAD-65-labeled neurons exhibiting a range of firing properties, including tonic firing and delayed firing. If singlespiking, tonic, and gap/delay cell populations in our study indeed represent functionally distinct groups, our results suggest that multiple postsynaptic cell types (including gap/delay cells) can exhibit postsynaptically-mediated glycinergic LTP. A non-competitive NMDAR antagonist completely prevented LTP, indicating that LTP was not caused by off-target effects of NMDA.
The potentiation was not accompanied by a significant decrease in the paired-pulse ratio, as expected if it were caused by an increased probability of glycine release. Instead, the LTP appears to result from a postsynaptic increase in glycine receptor number or function, as exogenously applied glycine currents were robustly increased after brief NMDA application. In this condition, the presynaptic release of glycine is not a factor, and instead this experiment confirms that NMDA treatment increases the postsynaptic response to glycine. The extracellular application of glycine might be expected to sample both synaptic and extrasynaptic glycine receptors. In considering the mechanism of potentiation, it is surprising to think of extrasynaptic glycine currents being enhanced after NMDA, as previous studies using single-particle tracking 
Postsynaptic Ca 2+ and NMDA Gly LTP
Bath-application of NMDA has often been used to mimic neuronal activation and to induce NMDAR-dependent synaptic plasticity. For example, NMDA induces LTD or LTP at excitatory synapses (Lee et al. 1998; Moreau and Kullmann 2013; Sharma et al. 2006 ) and can also potentiate GABAergic synapses, via Ca 2+ (Bannai et al. 2009; Bannai et al. 2015; Marsden et al. 2007; Petrini et al. 2014 ) and calcium/calmodulin-dependent protein kinase II (CaMKII) (Marsden et al., 2007; Petrini et al., 2014) . Similarly, glycinergic synapse strength is regulated by Ca 2+ influx and CaMKII (Charrier et al. 2010; Kirsch and Betz 1998; Xu et al. 2000; Yamanaka et al. 2013 ). In cultured spinal cord neurons, GlyR clusters and miniature Gly IPSC amplitudes are both markedly increased after NMDA treatment; moreover, clustering was prevented when Ca 2+ was chelated (Levi et al. 2008) . Consistent with a similar mechanism, we found that high intracellular EGTA prevented NMDA-induced GlyR LTP. Repetitive depolarization of the postsynaptic cell alone also proved sufficient to potentiate glycinergic synapses, as long as intracellular Ca 2+ was not chelated; similar repetitive depolarization potentiates GABAergic synapses in visual cortex slices (Kurotani et al. 2008 ). Importantly, low-frequency synaptic stimulation of primary nociceptor afferents was sufficient to potentiate glycinergic synapses on lamina II neurons, indicating that NMDAR-dependent GlyR LTP is elicited with physiological stimuli. Together our data are consistent with the idea that a rise in intracellular Ca 2+ through NMDARs at nociceptor synapses, or even during action potential firing of the postsynaptic cell driven by any mechanism, can potentiate glycinergic synapses, most likely by augmenting synaptic glycine receptor numbers/function.
In our occlusion experiments testing whether IL-1β and NMDA potentiate glycinergic synapses via a similar mechanism, potentiation by IL-1β always prevented further potentiation by NMDA.
This observation supports a common final pathway for potentiation by both agents. Ninety minutes after peripheral inflammation of the paw, glycinergic synapses on GAD-65 labeled neurons are potentiated, via a postsynaptic mechanism (Chirila et al., 2014); we originally attributed this to local release of IL-1β after injury (Samad et al., 2001; Raghavendra et al., 2004) .
Having shown here that NMDAR activation either by NMDA or during primary afferent stimulation also potentiates these synapses, however, the inflammation-induced potentiation could occur through either mechanism. Glutamate released from primary afferents stimulated at lowfrequency may elicit both release of IL-1β from dorsal horn glial cells and direct activation of NMDARs on lamina II neurons; both are expected to potentiate glycinergic synapses.
Circuit considerations
What is the role of glycine receptor LTP in the synapses on lamina II GABAergic neurons? Here we show that driving primary nociceptors for a brief period markedly potentiates glycine currents on lamina II neurons. Glycine receptor LTP in these neurons after peripheral inflammation 
